STAR

Strides Pharma Science Share Price

 

 

Start SIP in STAR

Start SIP

Performance

  • Low
  • ₹870
  • High
  • ₹886
  • 52 Week Low
  • ₹513
  • 52 Week High
  • ₹1,025
  • Open Price₹884
  • Previous Close₹883
  • Volume228,800
  • 50 DMA₹881.63
  • 100 DMA₹878.92
  • 200 DMA₹869.20

Investment Returns

  • Over 1 Month -7.03%
  • Over 3 Month -5.77%
  • Over 6 Month + 8.85%
  • Over 1 Year + 19.27%

Smart Investing Starts Here Start SIP with Strides Pharma Science for Steady Growth!

Invest Now

Strides Pharma Science Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 15.8
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 8,071
  • P/B Ratio
  • 2.9
  • Average True Range
  • 41.2
  • EPS
  • 59.78
  • Dividend Yield
  • 0.5
  • MACD Signal
  • -12.16
  • RSI
  • 50.33
  • MFI
  • 75.22

Strides Pharma Science Financials

Strides Pharma Science Technicals

EMA & SMA

Current Price
₹875.60
-6.9 (-0.78%)
pointer
  • Bearish Moving Average 6
  • Bullish Moving Average 10
  • 20 Day
  • ₹869.95
  • 50 Day
  • ₹881.63
  • 100 Day
  • ₹878.92
  • 200 Day
  • ₹869.20

Resistance and Support

877.18 Pivot Speed
  • R3 900.32
  • R2 893.13
  • R1 884.37
  • S1 868.42
  • S2 861.23
  • S3 852.47

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Strides Pharma Science Ltd. is a global pharmaceutical company engaged in the development, manufacturing, and marketing of generic drugs. It focuses on niche therapeutic segments, including anti-retrovirals, oncology, and central nervous system, serving markets worldwide.

Strides Pharma Science has an operating revenue of Rs. 4,725.61 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 11% is healthy, ROE of 140% is exceptional. The company has a reasonable debt to equity of 22%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its key moving averages, around -0% and 3% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 13% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 61 which is a FAIR score but needs to improve its earnings, a RS Rating of 80 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 74 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Strides Pharma Science Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-30 Quarterly Results
2025-10-31 Quarterly Results
2025-07-29 Quarterly Results
2025-05-22 Audited Results & Final Dividend
2025-01-30 Quarterly Results
Date Purpose Remarks
2025-07-22 FINAL Rs.4.00 per share(40%)Final Dividend
2024-09-09 FINAL Rs.2.50 per share(25%)Final Dividend
2023-08-04 FINAL Rs.1.50 per share(15%)Final Dividend
2021-08-06 FINAL Rs.2.50 per share(25%)Final Dividend
View Strides Pharma Science Dividend History Arrow

Strides Pharma Science F&O

Strides Pharma Science Shareholding Pattern

27.86%
8.59%
3.05%
29.52%
0.01%
21.41%
9.56%

About Strides Pharma Science

  • NSE Symbol
  • STAR
  • BSE Symbol
  • 532531
  • Managing Director & Group CEO
  • Mr. Badree Komandur
  • ISIN
  • INE939A01011

Similar Stocks to Strides Pharma Science

Strides Pharma Science FAQs

Strides Pharma Science share price is ₹875 As on 12 February, 2026 | 05:24

The Market Cap of Strides Pharma Science is ₹8070.6 Cr As on 12 February, 2026 | 05:24

The P/E ratio of Strides Pharma Science is 15.8 As on 12 February, 2026 | 05:24

The PB ratio of Strides Pharma Science is 2.9 As on 12 February, 2026 | 05:24

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23